Home / Feed item / CIRM: First patient treated in @intlstemcell trial for #Parkinsons disease with no adverse affects via @sandiegoscience. http://bit.ly/2fVYEEo
CIRM: First patient treated in @intlstemcell trial for #Parkinsons disease with no adverse affects via @sandiegoscience. http://bit.ly/2fVYEEo
Our Vision
OIRM will transform the treatment of incurable diseases, making Ontario a global leader in the development and dissemination and dissemination of stem cell-based products and therapies.
